Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
4 hedge funds and large institutions have $20.7K invested in Aptose Biosciences, Inc. in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 14 closing their positions.
75% less funds holding
Funds holding: 16 → 4 (-12)
86% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 14
96% less capital invested
Capital invested by funds: $487K → $20.7K (-$466K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$33.8K |
| 2 |
GG
Gleason Group
Prospect,
Kentucky
|
+$7.12K |
| 3 |
CSC
Caldwell Sutter Capital
Sausalito,
California
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
-$382K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$54.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$38K |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$6.49K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |
APTO Hedge Fund Activity: Q2 2025 in Review
4 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q2 2025, worth a combined $20.7K — down 96% from $487K a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of APTO and 2 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was DRW Securities, opening a new position worth an estimated $33.8K. The largest seller was Bleichroeder LP, exiting entirely with an estimated $382K sold.
- 4 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q2 2025, down from 16 in Q1 2025.
- Funds reported $20.7K of Aptose Biosciences, Inc. stock for Q2 2025, down 96% quarter-over-quarter.
- 2 funds opened new Aptose Biosciences, Inc. positions in Q2 2025 and 14 closed out, a net change of -12 holders.
- The largest Aptose Biosciences, Inc. buyer in Q2 2025 was DRW Securities, an estimated $33.8K added.
- The largest Aptose Biosciences, Inc. seller in Q2 2025 was Bleichroeder LP, an estimated $382K sold.
Based on aggregated 13F filings for Q2 2025.